androgen receptor/glucocorticoid receptor antagonist CB-03-10
Term · Oncology and biomedicine · MLC-T-ONC-010080
An orally bioavailable steroidal cortexolone derivative and antagonist of the androgen receptor (AR) and glucocorticoid receptor (GR), with potential antineoplastic activity. Upon oral administration, AR/GR antagonist CB-03-10 specifically binds to AR and GR, inhibits AR and GR activation, and prevents AR- and GR-mediated signaling. This leads to an induction of both extrinsic and intrinsic apoptotic pathways and inhibits cell growth in AR- and GR-overexpressing tumor cells. AR and GR are overexpressed in certain types of cancer cells and are involved in proliferation, survival and chemoresistance of tumor cells.
| Identifier | MLC-T-ONC-010080 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AR/GR antagonist CB-03-10 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010080",
"term": "androgen receptor/glucocorticoid receptor antagonist CB-03-10",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable steroidal cortexolone derivative and antagonist of the androgen receptor (AR) and glucocorticoid receptor (GR), with potential antineoplastic activity. Upon oral administration, AR/GR antagonist CB-03-10 specifically binds to AR and GR, inhibits AR and GR activation, and prevents AR- and GR-mediated signaling. This leads to an induction of both extrinsic and intrinsic apoptotic pathways and inhibits cell growth in AR- and GR-overexpressing tumor cells. AR and GR are overexpressed in certain types of cancer cells and are involved in proliferation, survival and chemoresistance of tumor cells.",
"synonyms": [
"AR/GR antagonist CB-03-10"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10/"
}
Record 1,091 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.